Business profile & competitive position
Axon Enterprise, Inc. is classified under Industrials / Aerospace & Defense, but its business model sits at the intersection of law-enforcement technology and enterprise software. The company supplies TASER energy devices, body cameras, in-car cameras, sensors, drones, counter-drone systems, and cloud-based evidence and records management. It also offers real-time operations software, AI-enhanced productivity tools, and immersive training. Customers span public- and private-sector agencies, and the company’s own 10-K filing notes that no single customer accounted for more than 10% of net sales in 2023, 2024, or 2025, which points to a diversified customer base rather than revenue concentration risk.
The company’s reported profitability metrics are modest for a business carrying a premium valuation. Net margin is 7.6% and return on equity is 7.3% as of the latest snapshot. Those numbers suggest that Axon is still reinvesting heavily and that its hardware business likely carries lower margins than a mature software-as-a-service model. At the same time, the company reported $1.3 billion in annual recurring revenue as of December 31, 2025, built from monthly recurring license, integration, warranty, and storage revenue. Manufacturing, final assembly, and final testing are performed at ISO 9001- and ISO 9001:2015-certified facilities in Arizona. Overall, the business looks like a platform with recurring-software characteristics, but its current returns on capital remain restrained by hardware mix, growth investment, and international expansion costs.
Financial posture
With a market capitalization of $25.0 billion, a trailing P/E of 96.1, a net margin of 7.6%, an ROE of 7.3%, and a beta of 1.47, Axon is priced as a high-growth compounder rather than a mature defense contractor. A P/E near 100 implies the market is capitalizing expectations of very strong earnings growth far into the future. Against that, a net margin of 7.6% and ROE of 7.3% are relatively low, meaning investors are paying for a future profit profile that the current income statement does not yet deliver.
Volatility is another hallmark of the current posture. The stock’s beta of 1.47 indicates that Axon is materially more volatile than the overall market. As of the November 16, 2026 snapshot, the price was $307.61, below a 50-day exponential moving average of $412.60, and the RSI stood at 28.7, a level often associated with short-term oversold conditions in technical analysis. The combination of a triple-digit valuation multiple and compressed current profitability explains why the stock can move sharply on quarterly results and guidance.
Strategic priorities & outlook
Axon’s most recent SEC 10-K filing lays out several operational priorities. The company is realigning its reporting structure into two segments: Software and Services, and Connected Devices. Management says the new structure is meant to reflect the growth of the recurring revenue base and to increase transparency between the software/services business and the hardware business.
Other stated priorities include continued international expansion across Europe, Asia, and the Americas; investment in sales personnel and strategic headcount to enter new markets; and ongoing research and development behind “purposeful product innovation.” The filing repeatedly emphasizes building “highly recurring, highly profitable businesses,” which suggests that management is trying to shift the margin mix toward the $1.3 billion recurring revenue stream. Investors tracking this story should watch whether gross and operating margins improve as the software/services segment grows, and whether new hardware categories such as drones and counter-drone systems dilute or expand blended profitability.
Macro & geopolitical exposure
As an Aerospace & Defense name, Axon is exposed to government spending, procurement cycles, and regulatory scrutiny at federal, state, and local levels. Public-safety budgets can be lumpy, and large agency rollouts of body cameras, cloud evidence systems, or drone platforms depend on appropriations and administrative approval timelines. Less-lethal weapons and surveillance devices also face regulatory and policy debates that can affect adoption speed or contract terms.
International expansion adds currency, trade, and compliance considerations. Drone and counter-drone technology can be subject to export controls and foreign-investment screening in certain markets, while cloud-based evidence systems must satisfy local data-residency, privacy, and cybersecurity rules. The sector’s supply chain—ensors, cameras, semiconductors, batteries, and specialty components—can also be sensitive to trade policy and geopolitical tension. These macro factors do not54:46.32589:08.501affect the company identically in every quarter, but they are relevant background conditions for any Industrials / Aerospace & Defense company selling hardware and software to public agencies.
Recent developments
A cluster of recent headlines has kept Axon in the news. On November 15, 2026, defenseworld.net reported that Aberdeen Group plc boosted its AXON holdings. That same week, on November 13, 2026, Levi & Korsinsky issued a securities investigation notice, while Zacks.com published a piece asking whether investors should buy, hold, or sell AXON stock post-Q3 earnings. The day before, on November 12, 2026, Zacks.com also noted that Axon was attracting investor attention.
The catalyst for much of that attention is the November 5, 2026 earnings release. Axon reported actual EPS of $1.72 versus an estimate of $1.89, a -9% surprise and a miss. The stock fell 18.18% the next trading day and declined 19.72% over the following five sessions. That price action—combined with the current quote of $307.61, an RSI of 28.7, and a 50-day EMA of $412.60—shows that the November miss has put the stock in a technically oversold position relative to its recent trend. The elevation in attention simply reflects how consequential the Q3 report was for near-term sentiment.
Earnings behavior & post-earnings drift
Over the past eight reported quarters, Axon has beaten earnings estimates six times, for a 75% beat rate. The average earnings surprise across those eight quarters is 14.3%. The average five-day price move after earnings has been 1.8%, classified as an “up” drift. Those headline numbers suggest that Axon has historically delivered better-than-expected results and that the stock has tended to drift higher over the week following a report.
The last four quarters, however, show how much one report can dominate the average. On February 24, 2026, Axon earned $2.15 per share versus a $1.60 estimate, a 34.4% positive surprise. The stock jumped 17.55% the next day and 30.86% over the next five trading days. On May 6, 2026, EPS came in at $1.61 against a $1.60 estimate, a 0.6% beat, and the stock rose 10.63% the next day but gave back 2.34% over the next five days. On August 5, 2026, EPS of $1.88 beat the $1.84 estimate by 2.2%, yet the stock still fell 14.28% the next day and drifted down another 1.59% over the following five sessions. Then came the November 5, 2026 report, which missed by -9% and triggered an 18.18% one-day drop and a 19.72% five-day decline.
Axon is next scheduled to report on February 23, 2027, after the market close, with a consensus EPS estimate of $1.98. The historical beat rate and average surprise argue that the company often exceeds analyst models, but the recent August and November reactions show that meeting or beating estimates is not always enough to move the stock higher. Guidance, valuation expectations, and the market’s real expectation can matter as much as the headline EPS number.
Frequently Asked Questions
What does Axon’s 7.6% net margin and 7.3% ROE suggest about its competitive position?
Those figures are relatively low for a company with a P/E ratio above 90. They imply Axon is still reinvesting heavily in hardware, international expansion, and headcount, so current profitability has not yet caught up to the platform’s recurring-revenue potential.
How has AXON stock typically reacted after earnings?
Over the last eight quarters, Axon has beaten estimates 75% of the time with an average surprise of 14.3%. The average five-day post-earnings drift has been 1.8% higher. However, the November 5, 2026 miss produced an 18.18% one-day drop and a 19.72% five-day decline, showing that individual reports can be violent.
What are Axon’s stated strategic priorities in its 10-K?
The company plans to realign reporting into Software and Services and Connected Devices segments, continue expanding internationally, add sales personnel and strategic headcount, and invest in R&D to build what it describes as “highly recurring, highly profitable businesses.”
For a deeper dive, compare these snapshots with the full institutional verdict, including consensus model assumptions, margin-trajectory estimates, and any updated guidance from management.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-11-05 | $1.72 | $1.89 | -9% | -18.18% | -19.72% |
| 2026-08-05 | $1.88 | $1.84 | +2.2% | -14.28% | -1.59% |
| 2026-05-06 | $1.61 | $1.6 | +0.6% | +10.63% | -2.34% |
| 2026-02-24 | $2.15 | $1.6 | +34.4% | +17.55% | +30.86% |
| 2025-11-04 | $1.17 | $1.52 | -23% | - | - |
| 2025-08-04 | $2.12 | $1.45 | +46.2% | - | - |
Previous AXON editions
Get the institutional verdict on AXON
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the AXON verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.